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The steadily increasing knowledge concerning selenium (Se) involvement 
in chronic autoimmune and viral inflammatory disease along with the 
growing prospect of preventive and/or therapeutic Se intervention, via 
diet or compounds, are the focus of this brief review. Important data on 
inflammation are provided, while the link between Se status and disease is 
described through an overview of the involvement of Se in the molecular 
mechanisms of inflammation. 
 
Se is an essential element incorporated in the form of selenocysteine 
(Secys) in the active site of selenoproteins, which are crucially involved in 
regulating immune response, oxidative stress, and chronic inflammation.1 
Thus, Se, being a constitutional component of deiodinases (DIO), plays 
a pivotal role in thyroid hormone metabolism and protection of the 
thyroid gland against oxidative stress-induced damage.2 In the 1980s, the 
observation of the development of myxoedematous cretinism and thyroid 
destruction following Se repletion in iodine- and Se-deficient children 
led to an increasing focus on Se research and thyroid pathophysiology.3,4 
Though minor amounts appear to suffice for adequate activity of DIOs, the 
maintenance of a Se steady state via Se intake, “selenostasis,” is required 
to preserve the activity of glutathione peroxidase (GPX1) and thioredoxin 1 
(TXRND1) in both thyroid and redox processes.5,6
Regarding more specifically TXNRD1, experimental studies showed that 
rats fed a Se-deficient diet exhibited decreased TXNRD1 levels in the 
kidney, liver, and lungs, while in the spleen and prostate the levels were 
unaltered compared with the rats fed a high Se diet.7 However, no increase 
was found in TXNRD1 protein synthesis, suggesting that the tissue-specific 
TXNRD1 increase was probably due to elevated Secys incorporation. 
Inflammation occurs in two types, namely acute and chronic inflammation, 
which can be defined respectively as a regulated and a dysregulated form 
of the disorder.8 Pro-inflammation is a common biologic phenomenon 
providing first-line defense against infection or invasion of pathogenic 
biologic agents, such as viruses, bacteria, and parasites. On the other hand, 
should the balance between pro- and anti-inflammatory mechanisms be 
disrupted, pro-inflammation can lead to wide-ranging detrimental effects. 
In this line of evidence, an increased differentiation and synthesis of 
pro-inflammatory Th17 cytokines, as has been observed in autoimmune 
thyroid disease (AITD) conditions and mainly in Hashimoto thyroiditis (HT), 
suggests that this phenomenon may have a pathogenetic role.9 In addition, 
low-grade inflammation can contribute via pathogenic mechanisms to 
developing insulin resistance, dyslipidemia, atherogenesis, type 2 diabetes 
mellitus (T2DM), and hypertension in obese individuals.10
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There is good evidence that Se could have a positive impact on the course 
and outcome of a number of etiologically inflammatory diseases.11–13 
Although the data are based almost exclusively on in vitro studies, and 
certainly caution is advised in interpreting the results, there are strong 
indications that viral-, bacterial-, and/or stress-induced inflammation 
could be variably influenced by Se availability. 
The aim of this study is to discuss, through reference to the latest relevant 
data, the impact of Se in health and disease, and especially in the context of 
viral and metabolic diseases. Discussion of Se and cancer has been avoided 
as it is a topic of a separate review; the same applies to Se and the thyroid 
since various recent studies and reviews exist that have dealt with this topic. 
Nevertheless, given that Se and chemoprevention and Se and the thyroid 
are today subjects of considerable significance, a brief report follows on the 
current state of knowledge of Se research in these two latter fields.
Selenium and Chemoprevention
It has been suggested that high Se levels are capable of protecting against 
several types of cancer. However, the Selenium and Vitamin E Cancer 
Prevention Trial (SELECT), a randomized, double-blind, placebo-controlled 
study that was conducted to assess the efficacy of Se and vitamin E, 
both alone and in combination, in the management of prostate cancer 
did not observe any reduction in the incidence of prostate cancer after 
7 years.14,15 A systematic review including trials involving 3,418 prostate 
cancer patients from 13 countries demonstrated that trials supplementing 
pomegranate seed, green tea, broccoli, soy, lycopene, Se, and coenzyme 
Q10, and comparing a low-fat diet versus a usual diet, displayed 
beneficial effects of Se on prostate cancer progression.16 In addition, 
Se nanoparticles loaded with anisomycin, an anticancer molecule, has 
recently been reported to improve antihepatocarcinoma efficacy.17 It is 
therefore advisable that in future studies of Se chemoprevention, the 
specific formulation of Se compounds and the dosage, the nutritional 
habits of the study cohort, the study design, and the age of participants 
and the baseline Se levels should be carefully considered. Relevant to the 
concept presented in this section is the fact that protein unfolding, which 
is involved in cancer development, can be inhibited by diet modifications, 
such as Mediterranean diet.18 Most particularly, it has recently been 
observed that Se from sodium selenite, reacts with free sulfhydryl groups 
of proteins, thus preventing reductive cleavage of disulfide bonds, this 
followed by protein unfolding and abnormal refolding.19,20
However, no convincing evidence exists either, which should be clearly 
stated, of a causal relation between Se and cancer that Se supplements 
can prevent cancer in humans.21
Selenium, Obesity, and Diabetes
In the SELECT study, higher rates of obesity were clearly observed among 
African American than non-Hispanic white men, possibly suggesting 
that reducing obesity among African American men could decrease the 
racial disparity in cancer incidence.22 In a study examining the association 
between Se status and metabolic risk factors in men with visceral obesity, 
Se was positively correlated with high-density lipoprotein (HDL) and 
fatty acid binding protein-4, (FABP4), while GPX3 activity was negatively 
correlated with FABP4.23 In obese men who had at least one component of 
the metabolic syndrome (MS), GPX3 activity was positively correlated with 
HDL. These findings indicate that Se status is linked to metabolic risk factors 
only in particular groups of obese men with or without MS.22 This partially 
accords with recent animal studies suggesting a risk that long-term high Se 
intake could induce insulin resistance and T2DM.24 It has meanwhile been 
shown that high Se intake (0.5–3 mg/kg of diet) results in insulin resistance 
and diabetes-like states in animals. Though the mechanism is as yet 
unclear, upregulation, via high Se intake of selenoproteins such as GPX1, 
selenoprotein S (SELS) and selenoprotein P (SEPP), β-cells, insulin synthesis, 
and secretion, resulting in hyperinsulinemia as well as dysfunction of major 
regulators of glycolysis, gluconeogenesis, and lipolysis.24
 
In humans, the results from observational cross-sectional studies have 
raised concern that high Se exposure may be associated with T2DM or 
insulin resistance, at least in well-nourished populations.25,26 Therefore, 
the interactive role of Se, and especially the deleterious role of selenosis 
(Se toxicity) in diabetogenesis, should be considered when long-term 
studies with high Se intake are implemented. 
Additionally, plasma Se and GPX levels were found to be low in T2DM 
patients with macroalbuminuria and were related to the stage of diabetic 
nephropathy.27 Also, in patients with chronic kidney disease (CKD), both 
Se and plasma glutathione peroxidase (GSH-PX), which is synthesized in 
the kidney using Se as a cofactor, were reduced, especially in those who 
were on hemodialysis.28 However, while supplementation of Se in such 
cases significantly increased Se levels, its impact on GSH-PX levels was 
modest, the only means of adequately restoring them in these subjects 
being via kidney transplantation.28 In an experimental study, when Se was 
supplemented in the form of sodium selenite to diabetic rats, glucose 
uptake and its turnover, which is usually decreased in diabetic rats, 
showed a statistically significant increase.29
Thus, there is some evidence suggesting that Se plays an insulin-like 
mediating role in diabetes by tending to normalize the altered activities 
of glucose metabolizing enzymes and improving glucose uptake and 
metabolism by the liver.30
Recently, it was reported that selenocysteine-β-lyase (Scly), a protein 
that mediates Secys degradation and relates selenoproteins to energy 
metabolism, may have an effect on obesity and MS development triggered 
by high-fat exposure.31 Scly knock-out mice developed MS and had 
normal inflammatory cytokines and expression of selenoproteins, except 
of SEPP1.32 Thus, disruption of Scly favors obesity independent of the 
expression of most selenoproteins.32
Selenium and the Thyroid 
While the immune system acts to protect the host from infectious agents 
and from other noxious insults that exist in the environment, an abnormal 
immune response to autoantigens that express on the thyrocytes in 
genetically susceptible persons can trigger AITD. The most frequent AITD 
is HT,33 which is more common in females and increases with age,34 with 
primary hypothyroidism being a frequent consequence of HT. 
Se is copiously present in the thyroid gland. Inflammatory thyroid follicular 
cells produce a large number of cytokines, such as Th1, which play a 
crucial role in the pathogenesis of AITD. Se supplementation in rats is 
likely to regulate the expression of Th1/Th2 cytokines and alleviate AITD.36 
The selenoprotein DIO comprises enzymes that convert the depot thyroid 
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hormone thyroxine to the active triiodothyronine and inactive reverse-
triiodothyronine.36 During the process of conversion, hydrogen peroxide, 
a toxic byproduct, is generated, which is neutralized by GPX thus 
preventing oxidative stress, thyroid cell damage, and disease. However, 
interventional clinical trials have provided somewhat controversial results 
regarding the efficacy of organic and inorganic Se compounds, in the form 
of selenomethionine (SeMet) and selenite, respectively, in patients with 
autoimmune thyroiditis.37,38 Se-enriched yeast (Se-yeast) is another form of 
Se supplementation.39 With elucidation of the manner in which speciation 
of Se-yeast is achieved, it was revealed that SeMet is the largest single 
species, making up 54–74 % of total Se. Moreover, it has been determined 
that Se-yeast is capable of elevating selenoenzymes activity and that 
its bioavailability is higher than that of inorganic Se.39 It consequently 
translates as an effective, safe (no toxicity has been observed), and natural 
source of dietary Se, though attention must be paid to the variability of Se 
content of various diets in accordance with food items, their geographical 
origin, and the corresponding soil Se content.40 In future prospective 
trials, the stage of disease, the iodine baseline state, and the form of the 
Se compound should be given particular consideration. 
While Se administration has proved efficacious in patients with mild 
thyroid-associated opthalmopathy,41 it has also recently been shown that 
low serum Se levels are associated with increased incidence of thyroid 
disease and that increased Se intake lowers the risk for disease.42 It 
therefore seems evident that Se status could well be a valuable marker 
of thyroid disease risk.  
Selenium and Chronic Inflammation 
Persistent acute inflammation may suppress hypersensitivity, heighten 
susceptibility to toxic agents, and increase bodily requirements of Se. 
Such a condition will inevitably derange the body’s “selenostasis,” 
creating a state of Se deficiency as well as causing chronic inflammatory 
disorders and the so-called “immune tsunami” that characterizes several 
various autoimmune diseases.43 
Reactive oxygen species (ROS) formed during oxidative stress can 
damage normal cellular function by initiating lipid peroxidation and also 
cause DNA strand breaks. Routine clinical procedures, such as coronary 
bypass surgery and thrombolysis, are typically followed by generation 
of ROS, this being associated with poor cardiac recovery postischemia. 
Furthermore, ROS have recently been reported to be strongly involved 
in infarction, necrosis, apoptosis, arrhythmogenesis, and endothelial 
dysfunction following ischemia-reperfusion.44 Meanwhile, increased 
production of ROS necessitates high requirements of nutrients involved 
in antioxidant defenses, and notably Se and zinc. In this context, constant 
dietary Se supplementation may provide a safe and convenient method 
for increasing antioxidant protection in patients at risk for ischemic heart 
disease or in those undergoing clinical procedures involving transient 
periods of myocardial hypoxia.45
In a study of 77 patients in whom, after cardiopulmonary resuscitation 
(CPR), Se levels were found to be lowered and to be inversely correlated 
with the clinical outcome, administration of Se exerted anti-inflammatory 
effects and prevented microparticle-mediated endothelial dysfunction.46 
Endothelial dysfunction is, moreover, a pivotal feature of postcardiac arrest 
syndrome a life-threatening state with high mortality, which is also driven 
by microparticles in resuscitated patients. Interestingly, Se administration 
diminished intercellular adhesion molecule-1- and vascular cell adhesion 
molecule-1-mediated monocyte adhesion induced by microparticles of 
CPR patients.46 Of note, the fact that Se declines in plasma of patients 
following CPR could possibly identify it as a novel predictive marker of 
intensive care unit mortality.
Viral and bacterial infections are often associated with low Se, among 
deficits of other macronutrients and micronutrients. For example, benign 
Coxsackie and influenza virus strains can mutate to highly pathogenic 
strains in the presence of Se deficiency.47 On the other hand, multi-
micronutrient supplements containing Se have been shown to improve 
a number of clinical and lifestyle variables in patients simultaneously 
infected with HIV and mycobacterium tuberculosis. The hypothesis in the 
latter case is that boosted Se status may upgrade the function of both 
adaptive and innate immunity cells.47
Se administration is thought to be beneficial to patients suffering from 
viral diseases. In an experimental study, the effects of Se supplementation 
on serum Se concentrations, mortality rate, lung virus, and cytokine titers 
were measured in mice inoculated with suspensions of the influenza 
virus.48 Basal Se levels were seen to be of major importance as mortality 
amounted to 75 % in Se-deficient mice compared with a 25 % mortality rate 
in the mice supplemented with 0.5 mg Se/kg in the form of sodium selenite. 
These results suggest that Se may represent a valid intervention approach 
for strengthening the immune response to lethal influenza virus infection.48
Other potential targets for intervention via Se supplementation are gut 
epithelial barrier dysfunction, innate immune activation, inflammation, and 
other factors that may independently predict mortality in individuals with 
treated HIV infection with a history of AIDS.49 It is important to note, however, 
that although single and multiple micronutrient deficiencies are common 
among HIV-infected adults pre-antiretroviral therapy (ART) initiation, their 
levels are likely to vary between countries50. Thus, in PEARLES, a nine-
country trial, it was investigated whether the prevalence and multiple 
micronutrient deficiencies among HIV-infected adults changed 48 weeks 
post-ART initiation.50 Importantly, despite increases in micronutrient 
concentrations, prevalence of individual deficiencies remained largely 
unchanged after 48 weeks on ART. Among all micronutrients, Se deficiency 
(53  %) has the highest prevalence among these patients. The above 
results suggest that ART alone is not sufficient to improve micronutrient 
deficiency.50 Working on the basis of these findings, a randomized clinical 
trial (RCT) demonstrated that 24-month Se supplementation significantly 
increases the rate of CD4 cell count, which is known to decline among 
ART-naive patients.51
Se may provide protection against viral diseases, as was first shown in 
the successful treatment and prevention of Keshan disease, a form of 
myocarditis mainly occurring in regions of China that are characterized 
by very low Se levels.52 It is well known that a cofactor in the etiology of 
Keshan disease is Coxsackievirus B3 (CVB3), which is thought to become 
more virulent in a low Se environment.53–55
Furthermore, conditions of oxidative stress sustained by an Se-deficient 
state are likely to genetically influence the virus, causing mutations 
that further impair immunity, thus promoting and exacerbating chronic 
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inflammation. Meanwhile, low Se levels might be associated with 
underactivity of several selenoproteins and higher mortality.56
Se concentrations were reduced in critically ill patients, presumably 
due to Se consuming oxidative stress, and particularly in patients with 
sepsis.57 Thus, oxidative stress might be a result of suboptimal Se and 
zinc concentrations.57 Se supplementation may restore Se levels and 
increases shedding of L-selectin from monocytes while decreasing soluble 
L-selectin, which has been reported to be associated with high mortality 
in patients with sepsis.58 However, there is currently some uncertainty 
regarding its efficacy, as major questions remain unanswered concerning 
dose, duration of supplementation, and species of Se administered.
  
Recently, serum Se levels were seen to be drastically decreased in 
alcoholic liver disease patients, this accompanied by low GPX activity.59 
The serum Se/malondialdehyde (MDA) ratio, as a marker of oxidative 
stress, has been proposed as an indicator of hepatic damage caused by 
alcohol consumption and, notably, Se substitution emerged as a possible 
antioxidant therapy in these patients. 
In the course of inflammatory bowel diseases (IBDs), absorption disorders, 
and consequent malnutrition results in trace element deficiencies, 
and especially of Se, thus impairing the body’s antioxidant protection 
system.60 It thus seems intuitive to propose that a nutrition therapy for IBD 
that would include Se, energy-protein nutrients, and other trace elements 
could well prove beneficial.60
 
In acute pancreatitis, a disease with a high mortality rate, Se support 
remains controversial due to several factors, such as lack of agreement 
as concerns mode of administration and classification of the disease.61 
However, in chronic pancreatitis, as was shown in a recent meta-analysis, 
combined antioxidant (Se, β-carotene, vitamin C, vitamin E, methionine) 
therapy was seen to be associated with pain relief and thus could improve 
the quality of life of these patients.62 
Selenium and Mechanisms of Inflammation
Chronic inflammation leads to Se deficiency, which intensifies the 
persistence of the inflammatory condition and, by creating a vicious 
cycle, promotes the manifestation of disease. In a state of low Se, cells 
create a selenoprotein hierarchy, since they utilize Se to synthesize the 
selenoproteins most important to them.63 The liver, the central organ for 
Se regulation, produces excretory Se forms to regulate whole body Se. It 
responds to Se deficiency by curtailing excretion and secreting SEPP into 
the plasma at the expense of its intracellular selenoproteins availability. 
Meanwhile, studies have indicated that supranutritional Se increases 
proliferation as well as differentiation of naive CD4-positive T lymphocytes 
toward T helper 1 cells, thereby enhancing acute cellular immune response 
(see Figure 1).64,65
Two endoplasmic reticulum (ER) transmembrane selenoproteins that 
have been associated with inflammation and immunity, SELK and SELS, 
have recently been proposed as playing a role in protecting cells during 
conditions that lead to ER stress.66 With regard to SELS, its role is likely to 
be linked to its function in retrograde translocation of misfolded proteins 
from the ER.67 Besides playing a pathologic role in various diseases, chronic 
inflammation can be caused by both genetic and environmental factors.68 
Genetic variation in SELS, which is strongly involved in stress response 
in the ER, showed that one promoter variant, -105G-A, was associated 
with the cytokines interleukin (IL)-1β, IL-6, and tumor necrosis factor 
alpha (TNF-α) and that functional analysis of this polymorphism revealed 
SELS impairment following exposure to ER stress agents.67 Moreover, 
suppression of SELS in macrophages led to increased release of IL-6 and 
TNF-α, indicating that SELS is involved in mediating inflammation.67
  
The nuclear factor kappa-B (NFκB) signaling pathway has been 
associated with enhanced inflammatory response, while its activation 
has been significantly correlated with IL-6 and TNF-α production.69 It is 
hypothesized that Se may be capable of inhibiting the activation of NFκΒ 
by modulating selenoprotein gene expression. In chronic inflammation, 
Se supplementation has been shown to restore the depleted hepatic 
and serum Se levels by increasing selenoprotein biosynthesis, this 
Molecular mechanisms of inflammation induction mediated by activation of nuclear 
factor kappa-B (NFκB) that likely activate transcription of Wnt5α and increase expression 
of pro-inflammatory cytokines, such as interleukin (IL)-1 and IL-6, which in synergy may 
stimulate the synthesis of C-reactive protein (CRP) in the liver. Selenium intake may 
inhibit the activation of NFκB and mitigate the synthesis of CRP. TLR = toll-like receptor.
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leading to suppressed C-reactive protein (CRP) production thereby 
attenuating the inflammatory process.70 Moreover, Se downregulates the 
expression of nuclear transcription NFκB, lipoxygenase, cyclooxygenase, 
5-lipoxygenase-activating protein, and receptor for leukotriene B4.71 By 
decreasing the production of ROS and suppressing the activation of NFκB-
mediated transcription of pro-inflammatory mediators, Se leads to the 
downregulation of the leukotriene pathway and attenuates inflammation 
such as in diabetic cardiac hypertrophy.71
At the epigenetic level, an investigation was made into the effect of Se 
supplementation in the form of selenide on histone acetylation in models 
of inflammation.72 Se inhibits histone H4 acetylation in macrophages, thus 
confirming a role of Se in downregulating inflammatory gene expression.72
 
These mechanisms may explain the modulatory effects of an increased 
Se status on the inflammatory response (see Figure 2).
The ability of Se to act as a free radical scavenger could prove useful 
in counteracting the generation of hydroxyl radicals and subsequent 
formation of insoluble parafibrin from soluble plasma fibrinogen.73 The 
formation of a large protease resistant polymer formed by the hydroxyl 
radical interaction with fibrinogen in inflammation, which, if remaining 
long in the circulation, promotes a state of chronic inflammation, is due 
to the catalytic participation of trivalent iron (Fe3+), not of divalent (Fe2+), 
and to the attraction of cytotoxic albeit ineffective T cells.74 It should at 
this point be borne in mind that any pathologic condition involving the 
damage of erythrocyte membranes, as for example in infections and 
following exposure to environmental toxins, is likely to contribute to an 
excess of the body’s storage of trivalent iron. Certainly, it remains to be 
studied whether Se supplementation, as a free radical scavenger, with or 
without iron-chelating agents, may prevent iron overload and persistence 
of fibrin-like deposits, thus preventing cancer and cardiovascular and 
degenerative disease. 
Future Perspectives
There is a considerable amount of evidence to support Se administration, 
alone or in combination with other antioxidants, in chronic inflammatory 
diseases, such as chronic pancreatitis and AIDS. Though inflammation 
decreases Se levels, it is necessary to emphasize that, whereas Se 
supplementation may benefit patients with low Se status, it should not be 
recommended to those with adequate-to-high status since administration 
could affect them adversely, notably causing selenosis, which is 
characterized by a variety of symptoms, including nausea, vomiting, 
abdominal pain, diarrhea, hair loss, brittle nails, and peripheral neuropathy. 
Existing data suggest that Se administration could be beneficial in an array 
of metabolic and autoimmune diseases that are related to inflammation. 
More specifically, there is potential for future use of Se in several 
autoimmune diseases, applying it alone in a personalized model while 
utilizing more sophisticated and targeted formulations, which will offer 
the advantage of higher efficacy and a lower rate of side effects. However, 
controversies as yet exist regarding choice of Se species, dosage, and 
duration of administration. 
Therefore, much work still needs to be carried out, with the performance 
of large RCTs being required in order to establish whether Se 
supplementation in chronic inflammatory states may have a positive 
impact on disease progression and mortality. n
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